Search results for: FLARE

Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease

Simon M. Helfgott, MD | May 1, 2013

Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders

ACR Winter Rheumatology Symposium: Tips for ANCA Testing

Kimberly Retzlaff | May 1, 2013

How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein | March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD | March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein | February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten | January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

Depression in Rheumatoid Arthritis

Perry M. Nicassio, PhD, and Myra Irani, MA | November 1, 2012

Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP | November 1, 2012

Information on new approvals and medication safety rheumatologists need to know